Physician

Julio Jose Hajdenberg, MD

According to 2025 Medicare claims, Julio Hajdenberg, MD (NPI: 1255315958) practices hematology/oncology in the Portland-South Portland, ME market, with the plurality of this provider's patient population coming from York, ME. This provider's primary affiliated billing organization is MAINE CENTER FOR CANCER MEDICINE & BLOOD DISORDERS, P.A. (NPI: 1205896107; TIN: 010357684) and primary practice location at 04043-6078.

Hajdenberg's data goes back to 2015 and runs through 2024. For example, in 2021, this provider had 272 traditional Medicare patients, billed 714 HCPCS/CPT codes, and received $57,909 in Medicare payments. 2022 Part D data shows 104 prescription claims across 39 beneficiaries totaling $311,473 in drug costs. 2016 DME data shows 28 claims. Open Payments data shows 1 records totaling $400. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $2,041,532 and ending at $311,473. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$29K$58K2015 Medicare payment: $56,700 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $48,826 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $42,722 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $50,424 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $57,591 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $48,877 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $57,909 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015296877$56,700
2016323788$48,826
2017272680$42,722
2018305806$50,424
2019345914$57,591
2020318784$48,877
2021272714$57,909
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$3.1M$6.2M2015 Drug cost: $2,041,532 (USD; Tot_Drug_Cst)2016 Drug cost: $2,563,400 (USD; Tot_Drug_Cst)2017 Drug cost: $1,521,869 (USD; Tot_Drug_Cst)2018 Drug cost: $1,305,260 (USD; Tot_Drug_Cst)2019 Drug cost: $2,289,612 (USD; Tot_Drug_Cst)2020 Drug cost: $4,068,215 (USD; Tot_Drug_Cst)2021 Drug cost: $6,238,419 (USD; Tot_Drug_Cst)2022 Drug cost: $311,473 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015112710$2,041,532
2016121789$2,563,400
2017107586$1,521,869
2018119463$1,305,260
2019128514$2,289,612
2020147773$4,068,215
2021150953$6,238,419
202239104$311,473
2023N/RN/RN/R
2024N/RN/RN/R

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$2.0K$4.0K2015 Medicare payment: $4,019 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $2,393 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R39$4,019
2016N/R28$2,393
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

No connected Part D drug-level records for 2024.

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$400AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Julio Jose Hajdenberg, MD?

Tedicare shows public-source Medicare data for Julio Jose Hajdenberg, MD (NPI 1255315958), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Julio Jose Hajdenberg, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Julio Jose Hajdenberg, MD?

Julio Jose Hajdenberg, MD is linked to MAINE CENTER FOR CANCER MEDICINE & BLOOD DISORDERS, P.A. (billing NPI 1205896107) in the available physician profile data.

Does Julio Jose Hajdenberg, MD have Open Payments data?

Julio Jose Hajdenberg, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.